Product Name: Dopamine beta Hydroxylase antibody
Applications: IHC-P, WB
Predicted Target Size: 69 kDa (note)
Positive Controls: SH-SY5Y
Form Supplied: Liquid
Concentration: 0.72 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: dopamine beta-hydroxylase (dopamine beta-monooxygenase)
Background: The protein encoded by this gene is an oxidoreductase belonging to the copper type II, ascorbate-dependent monooxygenase family. It is present in the synaptic vesicles of postganglionic sympathetic neurons and converts dopamine to norepinephrine. It exists in both soluble and membrane-bound forms, depending on the absence or presence, respectively, of a signal peptide. [provided by RefSeq]
Synonyms: DBM antibody, DBH antibody, dopamine beta-hydroxylase antibody, dopamine beta-hydroxylase (dopamine beta-monooxygenase) antibody
Cellular Localization: Soluble dopamine beta-hydroxylase: Cytoplasmic vesicle , secretory vesicle lumen , Cytoplasmic vesicle , secretory vesicle , chromaffin granule lumen , secretory vesicle membrane , chromaffin granule membrane
CAS NO: 491-54-3
Product: Bosentan (hydrate)
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human Dopamine beta Hydroxylase. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human, Mouse, Rat
Conjugation: Unconjugated
Storage Buffer: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/20647777?dopt=Abstract
